answer text |
<p>The Department’s National Institute for Health Research (NIHR) welcomes funding
applications for research into any aspect of human health, including the development
of cheaper vaccines. These applications are subject to peer review and judged in open
competition, with awards being made on the basis of the importance of the topic to
patients and health and care services, value for money and scientific quality. In
all disease areas, the amount of NIHR funding depends on the volume and quality of
scientific activity.</p><p> </p><p>The NIHR and the Medical Research Council both
have a wide portfolio of research activity in vaccines which cover clinical trials
for new vaccines, new technologies, ways of improving uptake and cost effectiveness.</p>
|
|